secwatch.observer — SEC 8-K summary
======================================

Issuer:     iBio, Inc. (IBIO)
CIK:        0001420720
Form:       8-K
Filed at:   2025-06-24T23:59:59+00:00
Accession:  0001420720-25-000029
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

iBio updates corporate presentation highlighting obesity and cardiometabolic disease antibodies
--------------------------------------------------------------------------------

- Filed updated corporate presentation dated June 2025 for investor meetings.
- Presentation focuses on breakthrough antibodies for obesity and cardiometabolic diseases.
- No financial or pipeline specifics disclosed in the filing or attached exhibit.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1420720/000142072025000029/0001420720-25-000029-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1420720/000142072025000029/ibio-20250624x8k.htm
  HTML page:      https://secwatch.observer/filing/0001420720-25-000029

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer